NYKODE THERAPEUTICS ASA: årsregnskap 2020 vs 2019
Grew 1633% on revenue, returned to profit
approved 2021-05-05; registry 2021-09-15; journal 2021 708300
Summary
What changed
Comparing Årsregnskap 2020 with 2019 for NYKODE THERAPEUTICS ASA. Revenue 12.45m NOK → 215.69m NOK (+1633.0%). Net result -13.70m NOK → +149.77m NOK. Equity 268.44m NOK → 178.85m NOK.
On the constructive side: revenue rose; operating result improved; turned profitable. Pressures included: equity eroded.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 12.45m NOK to 215.69m NOK (+1633.0% YoY). Calculated
-
↑
Operating result improved
Operating result -13.94m NOK → +178.26m NOK (op. margin -112.0% → 82.6%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 13.70m NOK to a profit of 149.77m NOK. Calculated
-
↑
Cash rose
Bank deposits 89.26m NOK → 183.85m NOK (+106.0% YoY). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 268.44m NOK → 178.85m NOK (equity ratio 91.9% → 77.8%). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 514.52m NOK → 65.09m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 35.6k NOK → 556.0k NOK. Reported fact